ericsphotography / iStockphoto.com
The US Court of Appeals for the Federal Circuit has ordered the Patent Trial and Appeal Board (PTAB) to reconsider its assessments in three inter partes reviews (IPRs), in the wake of the US Supreme Court’s SAS Institute v Iancu decision.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
BioDelivery, Aquestive, inter partes review, patent invalidation, post grant proceedings, unpatentability, US Court of Appeals for the Federal Circuit, SAS